{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/pityriasis-rosea/background-information/prevalence/","result":{"pageContext":{"chapter":{"id":"090f1bfe-2513-53a8-ade3-e8368ec7d5d6","slug":"prevalence","fullItemName":"Prevalence","depth":2,"htmlHeader":"<!-- begin field 111bc831-17de-4d62-bc74-67efb4c95024 --><h2>How common is it?</h2><!-- end field 111bc831-17de-4d62-bc74-67efb4c95024 -->","summary":"","htmlStringContent":"<!-- begin item cfa2c99f-bdf0-4c2c-a58b-6fa861c271db --><!-- begin field a5e9231a-62e0-46bb-8f22-0748fd48e17a --><ul><li>The estimated prevalence of pityriasis rosea in the community is 1.3%; estimated annual incidence is 0.5–2% [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pityriasis-rosea/references/\">Zawar et al, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pityriasis-rosea/references/\">Chuh and Zawar, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pityriasis-rosea/references/\">Eisman and Sinclair, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pityriasis-rosea/references/\">Drago, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pityriasis-rosea/references/\">Contreras‐Ruiz, 2019</a>].<ul><li>CKS did not find any data on the prevalence of pityriasis rosea in the UK.</li></ul></li><li>In temperate climates, pityriasis rosea is seen more commonly during the winter months [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pityriasis-rosea/references/\">Sterling, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pityriasis-rosea/references/\">Villalon-Gomez, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pityriasis-rosea/references/\">Y&uuml;ksel, 2019</a>].</li><li>Most cases of pityriasis rosea occur in people aged 10–35 years:<ul><li>It is less common in infancy, early childhood, and older people [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pityriasis-rosea/references/\">Drago, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pityriasis-rosea/references/\">Sterling, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pityriasis-rosea/references/\">Eisman and Sinclair, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pityriasis-rosea/references/\">Urbina, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pityriasis-rosea/references/\">PCDS, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pityriasis-rosea/references/\">Villalon-Gomez, 2018</a>].</li><li>It is slightly more common in females — the reported female to male ratio is 1.1–1.4:1 [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pityriasis-rosea/references/\">Chuh et al, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pityriasis-rosea/references/\">Contreras‐Ruiz, 2019</a>].</li></ul></li></ul><!-- end field a5e9231a-62e0-46bb-8f22-0748fd48e17a --><!-- end item cfa2c99f-bdf0-4c2c-a58b-6fa861c271db -->","topic":{"id":"c96d68c3-bb0b-5b8c-b256-6b3e415d7ab2","topicId":"76763692-46bc-4f1e-add3-6c012ccd584a","topicName":"Pityriasis rosea","slug":"pityriasis-rosea","lastRevised":"Last revised in April 2020","chapters":[{"id":"82c04d82-7b6f-594a-8190-44f70c341f1b","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"0b21af5b-81ad-5b28-9df9-d6b7c4fdd3d4","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"357337fc-eefc-5ff8-84bf-cc4e15f9a2da","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"67565f4b-e371-5339-8d04-8fb65cb26c28","slug":"changes","fullItemName":"Changes"},{"id":"3b3d1372-8e27-5563-9a36-273677bd9a82","slug":"update","fullItemName":"Update"}]},{"id":"75f5c2f6-34b3-5b64-ab41-c7457b8eedd9","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"26135976-eb67-5dd8-ad15-9a98086871b7","slug":"goals","fullItemName":"Goals"},{"id":"96f6df37-1ba4-5020-8435-cbeac8de1488","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"026de696-4951-5e10-a246-456d67c1fea8","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"03d26d2a-90f8-53c5-97e9-cff9d95ae299","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"87a8200e-6cd0-588d-8d4b-86117be364e6","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"ba1ef82b-8a8a-558d-a84a-552083dcd2e1","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"a8f04415-38ec-5eb9-8282-733c37db5bac","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"38f858f2-48f8-54e6-bb01-5b58106435cc","slug":"definition","fullItemName":"Definition"},{"id":"f7fffe58-e2a4-5913-8a5a-354aad8d52f0","slug":"causes","fullItemName":"Causes"},{"id":"090f1bfe-2513-53a8-ade3-e8368ec7d5d6","slug":"prevalence","fullItemName":"Prevalence"},{"id":"20025f23-bbb9-5095-9acc-da8d9e15840b","slug":"prognosis","fullItemName":"Prognosis"},{"id":"72d63a33-0ca6-552f-81a8-200eef91d046","slug":"complications","fullItemName":"Complications"}]},{"id":"75dd0d1f-b162-54b6-b1ba-3833b13ae73e","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"44c5742e-2d6e-5ce6-806a-03940c5572f8","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"f2c8da26-1065-5bb2-add8-43b39f41b5fe","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"d71093b6-b130-5eeb-8e0f-443adf8be4aa","fullItemName":"Management","slug":"management","subChapters":[{"id":"0bc06d9c-42f1-5228-adf5-4eda9826e67a","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"c48f4302-0f7c-58d9-86ad-d5379d244e71","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"eee3f004-1425-502e-a455-287742b3ec77","slug":"emollients","fullItemName":"Emollients"},{"id":"51eb73bd-9e63-5028-815d-bf148fa863d9","slug":"topical-corticosteroids","fullItemName":"Topical corticosteroids"},{"id":"186fab77-8c30-557b-bd7b-f756eb8f9cab","slug":"antihistamines","fullItemName":"Antihistamines"}]},{"id":"b3c2db78-1290-58fb-9bb3-3a5db8e45669","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"e683b047-2b38-5f72-a4b8-c79a83946894","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"2d6d1b8c-ffc1-59d1-89f5-a5abdf200635","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"27361c81-c185-5b67-b396-0305d0519609","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"45051d9e-ec60-5c2c-b5ba-3144fa01ed3b","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"4e570021-eea5-51d7-a0b9-52d2862efb98","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"259f8083-da67-544d-b6f7-dbb776d27e96","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"4c25a2fe-3c87-5ac4-b4c3-7f8e41ff3c06","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"a8f04415-38ec-5eb9-8282-733c37db5bac","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}